Jindal Worldwide Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
JINDWORLD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jindal Worldwide Limited submitted its unaudited standalone and consolidated financial results for Q3 FY26 (quarter ended Dec 31, 2025) and the nine-month period, approved by the Board on Feb 13, 2026. Standalone revenue from operations fell to ₹53,845 lakhs in Q3 from ₹58,588 lakhs a year earlier (~8% YoY decline), while standalone PAT came in at ₹1,367 lakhs vs ₹1,420 lakhs. For the nine months, standalone revenue slipped to ₹1,56,490 lakhs from ₹1,66,884 lakhs, and PAT dropped to ₹4,305 lakhs from ₹5,309 lakhs. Consolidated Q3 revenue was ₹53,212 lakhs with PAT of ₹1,432 lakhs. The auditor (R. Choudhary & Associates) issued an unqualified limited review report with no qualifications. The company also sold its stake in Kashyap Tele-Medicines in May 2025 and reduced its holding in Goodcore Spintex, recording a loss on deconsolidation. EPS has been restated to reflect the 4:1 bonus issue done in March 2025.
The YoY decline in both revenue and profit, along with margin compression, signals weaker operational performance for the textile business in Q3. Investors should note the restated figures due to the bonus issue and the one-time loss from subsidiary divestments, which may distort quarter-on-quarter comparisons.